Join
Live feed
·
PRReleasevia Quantisnow
Impel Pharmaceuticals Inc. logo

Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

ByQuantisnow·Wall Street's wire, on your screen.
IMPL· Impel Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMPL (Impel Pharmaceuticals Inc.) and more on Quantisnow.